Literature Collection

Collection Insights

10K+

References

9K+

Articles

1400+

Grey Literature

4500+

Opioids & SU

The Literature Collection contains over 10,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Year
Sort by
Order
Show
10858 Results
7821
Proposal to reform North Carolina's Medicaid Program
Type: Government Report
Authors: North Carolina Department of Health and Human Services
Year: 2014
Publication Place: Raleigh, NC
Topic(s):
Healthcare Policy See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7822
Proposed Guidance for Toxicology Testing of Pregnant Patients
Type: Government Report
Authors: MaineMOM
Year: 2021
Publication Place: Augusta, ME
Topic(s):
Grey Literature See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7823
Proposed nurse-led initiatives in improving physical health of people with serious mental illness: A survey of nurses in mental health.
Type: Journal Article
Authors: Brenda Happell, Chris Platania-Phung, David Scott
Year: 2014
Topic(s):
Education & Workforce See topic collection
7825
Prospective acceptability of digital phenotyping among pregnant and parenting people with opioid use disorder: A multisite qualitative study
Type: Journal Article
Authors: E. Charron, A. White, K. Carlston, W. Abdullah, J. D. Baylis, S. Pierce, M. S. Businelle, A. J. Gordon, E. E. Krans, M. C. Smid, G. Cochran
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
7826
Prospective association of anxiety, depressive, and addictive disorders with high utilization of primary, specialty and emergency medical care
Type: Journal Article
Authors: Julian D. Ford, Robert L. Trestman, Karen Steinberg, Howard Tennen, Scott Allen
Year: 2004
Publication Place: Netherlands: Elsevier Science
Topic(s):
Financing & Sustainability See topic collection
7827
Prospective comparative assessment of buprenorphine overdose with heroin and methadone: Clinical characteristics and response to antidotal treatment.
Type: Journal Article
Authors: Bruno Megarbane, Anne Buisine, Frederic Jacobs, Dabor Resiere, Lucie Chevillard, Eric Vicaut, Frederic J. Baud
Year: 2010
Topic(s):
Opioids & Substance Use See topic collection
7828
Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenarios
Type: Journal Article
Authors: S. Johansson, M. A. Wallander, F. J. de Abajo, L. A. Garcia Rodriguez
Year: 2010
Publication Place: New Zealand
Abstract: BACKGROUND: Post-launch drug safety monitoring is essential for the detection of adverse drug signals that may be missed during preclinical trials. Traditional methods of postmarketing surveillance such as spontaneous reporting have intrinsic limitations, many of which can be overcome by the additional application of structured pharmacoepidemiological approaches. However, further improvement in drug safety monitoring requires a shift towards more proactive pharmacoepidemiological methods that can detect adverse drug signals as they occur in the population. OBJECTIVE: To assess the feasibility of using proactive monitoring of an electronic medical record system, in combination with an independent endpoint adjudication committee, to detect adverse events among users of selected drugs. METHODS: UK General Practice Research Database (GPRD) information was used to detect acute liver disorder associated with the use of amoxicillin/clavulanic acid (hepatotoxic) or low-dose aspirin (acetylsalicylic acid [non-hepatotoxic]). Individuals newly prescribed these drugs between 1 October 2005 and 31 March 2006 were identified. Acute liver disorder cases were assessed using GPRD computer records in combination with case validation by an independent endpoint adjudication committee. Signal generation thresholds were based on the background rate of acute liver disorder in the general population. RESULTS: Over a 6-month period, 8148 patients newly prescribed amoxicillin/clavulanic acid and 5577 patients newly prescribed low-dose aspirin were identified. Within this cohort, searches identified 11 potential liver disorder cases from computerized records: six for amoxicillin/clavulanic acid and five for low-dose aspirin. The independent endpoint adjudication committee refined this to four potential acute liver disorder cases for whom paper-based information was requested for final case assessment. Final case assessments confirmed no cases of acute liver disorder. The time taken for this study was 18 months (6 months for recruitment and 12 months for data management and case validation). To reach the estimated target exposure necessary to raise or rule out a signal of concern to public health, we determined that a recruitment period 2-3 times longer than that used in this study would be required. Based on the real market uptake of six commonly used medicinal products launched between 2001 and 2006 in the UK (budesonide/eformoterol [fixed-dose combination], duloxetine, ezetimibe, metformin/rosiglitazone [fixed-dose combination], tiotropium bromide and tadalafil) the target exposure would not have been reached until the fifth year of marketing using a single database. CONCLUSION: It is feasible to set up a system that actively monitors drug safety using a healthcare database and an independent endpoint adjudication committee. However, future successful implementation will require multiple databases to be queried so that larger study populations are included. This requires further development and harmonization of international healthcare databases.
Topic(s):
HIT & Telehealth See topic collection
7829
Prospective Multicenter Observational Study of 260 Infants Born to 259 Opiate-Dependent Mothers on Methadone or High-Dose Buprenophine Substitution
Type: Journal Article
Authors: Claude Lejeune, Laurence Simmat-Durand, Laurent Gourarier, Sandrine Aubisson
Year: 2006
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
7830
Prospects for Care Coordination Measurement Using Electronic Data Sources
Type: Government Report
Authors: K. M. McDonald, E. Schultz, T. Chapman, S. Davies, N. Pineda, J. Lonhar, E. Schmidt, S. Wilson
Year: 2012
Topic(s):
HIT & Telehealth See topic collection
,
Grey Literature See topic collection
,
Measures See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7831
Protecting pain patients. The evaluation of a chronic pain educational intervention
Type: Journal Article
Authors: Simon Holliday, Chris Hayes, Adrian Dunlop, Simon Morgan, Amanda Tapley, Kim Henderson, Briony Larance, Parker Magin
Year: 2017
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
7832
Protecting Youth Mental Health - The U.S. Surgeon General’s Advisory
Type: Web Resource
Authors: Office of the U.S. Surgeon General
Year: 2021
Publication Place: North Bethesda, MD
Topic(s):
Grey Literature See topic collection
,
Healthcare Policy See topic collection
,
Healthcare Disparities See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7834
Protocol for harmonization of randomized trials testing the addition of behavioral therapy to buprenorphine for opioid use disorder
Type: Journal Article
Authors: R. K. McHugh, A. J. Bailey, R. D. Weiss, G. M. Fitzmaurice
Year: 2024
Topic(s):
Opioids & Substance Use See topic collection
,
Measures See topic collection
7835
Protocol for the implementation of a statewide mobile addiction program
Type: Journal Article
Authors: C. A. Tschampl, C. Regis, N. E. Johnson, M. T. Davis, D. Hodgkin, M. F. Brolin, E. Do, C. M. Horgan, T. C. Green, B. Reilly, M. Duska, E. M. Taveras
Year: 2023
Abstract:

With overdose deaths increasing, improving access to harm reduction and low barrier substance use disorder treatment is more important than ever. The Community Care in Reach(®) model uses a mobile unit to bring both harm reduction and clinical care for addiction to people experiencing barriers to office-based care. These mobile units provide many resources and services to people who use drugs, including safer consumption supplies, naloxone, medication for substance use disorder treatment, and a wide range of primary and preventative care. This protocol outlines the evaluation plan for the Community in Care(®) model in MA, USA. Using the RE-AIM framework, this evaluation will assess how mobile services engage new and underserved communities in addiction services and primary and preventative care.

Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
7836
Protocol of an ongoing randomized controlled trial of care management for comorbid depression and hypertension: the Chinese Older Adult Collaborations in Health (COACH) study
Type: Journal Article
Authors: S. Chen, Y. Conwell, J. Xue, L. W. Li, W. Tang, H. R. Bogner, H. Dong
Year: 2018
Publication Place: England
Abstract: BACKGROUND: Depression and hypertension are common, costly, and destructive conditions among the rapidly aging population of China. The two disorders commonly coexist and are poorly recognized and inadequately treated, especially in rural areas. METHODS: The Chinese Older Adult Collaborations in Health (COACH) Study is a cluster randomized controlled trial (RCT) designed to test the hypotheses that the COACH intervention, designed to manage comorbid depression and hypertension in older adult, rural Chinese primary care patients, will result in better treatment adherence and greater improvement in depressive symptoms and blood pressure control, and better quality of life, than enhanced Care-as-Usual (eCAU). Based on chronic disease management and collaborative care principles, the COACH model integrates the care provided by the older person's primary care provider (PCP) with that delivered by an Aging Worker (AW) from the village's Aging Association, supervised by a psychiatrist consultant. One hundred sixty villages, each of which is served by one PCP, will be randomly selected from two counties in Zhejiang Province and assigned to deliver eCAU or the COACH intervention. Approximately 2400 older adult residents from the selected villages who have both clinically significant depressive symptoms and a diagnosis of hypertension will be recruited into the study, randomized by the villages in which they live and receive primary care. After giving informed consent, they will undergo a baseline research evaluation; receive treatment for 12 months with the approach to which their village was assigned; and be re-evaluated at 3, 6, 9, and 12 months after entry. Depression and HTN control are the primary outcomes. Treatment received, health care utilization, and cost data will be obtained from the subjects' electronic medical records (EMR) and used to assess adherence to care recommendations and, in a preliminary manner, to establish cost and cost effectiveness of the intervention. DISCUSSION: The COACH intervention is designed to serve as a model for primary care-based management of common mental disorders that occur in tandem with common chronic conditions of later life. It leverages existing resources in rural settings, integrates social interventions with the medical model, and is consistent with the cultural context of rural life. TRIAL REGISTRATION: ClinicalTrials.gov ID: NCT01938963 ; First posted: September 10, 2013.
Topic(s):
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
7837
Protocol of an ongoing randomized controlled trial of care management for comorbid depression and hypertension: the Chinese Older Adult Collaborations in Health (COACH) study
Type: Journal Article
Authors: S. Chen, Y. Conwell, J. Xue, L. W. Li, W. Tang, H. R. Bogner, H. Dong
Year: 2018
Publication Place: England
Abstract: BACKGROUND: Depression and hypertension are common, costly, and destructive conditions among the rapidly aging population of China. The two disorders commonly coexist and are poorly recognized and inadequately treated, especially in rural areas. METHODS: The Chinese Older Adult Collaborations in Health (COACH) Study is a cluster randomized controlled trial (RCT) designed to test the hypotheses that the COACH intervention, designed to manage comorbid depression and hypertension in older adult, rural Chinese primary care patients, will result in better treatment adherence and greater improvement in depressive symptoms and blood pressure control, and better quality of life, than enhanced Care-as-Usual (eCAU). Based on chronic disease management and collaborative care principles, the COACH model integrates the care provided by the older person's primary care provider (PCP) with that delivered by an Aging Worker (AW) from the village's Aging Association, supervised by a psychiatrist consultant. One hundred sixty villages, each of which is served by one PCP, will be randomly selected from two counties in Zhejiang Province and assigned to deliver eCAU or the COACH intervention. Approximately 2400 older adult residents from the selected villages who have both clinically significant depressive symptoms and a diagnosis of hypertension will be recruited into the study, randomized by the villages in which they live and receive primary care. After giving informed consent, they will undergo a baseline research evaluation; receive treatment for 12 months with the approach to which their village was assigned; and be re-evaluated at 3, 6, 9, and 12 months after entry. Depression and HTN control are the primary outcomes. Treatment received, health care utilization, and cost data will be obtained from the subjects' electronic medical records (EMR) and used to assess adherence to care recommendations and, in a preliminary manner, to establish cost and cost effectiveness of the intervention. DISCUSSION: The COACH intervention is designed to serve as a model for primary care-based management of common mental disorders that occur in tandem with common chronic conditions of later life. It leverages existing resources in rural settings, integrates social interventions with the medical model, and is consistent with the cultural context of rural life. TRIAL REGISTRATION: ClinicalTrials.gov ID: NCT01938963 ; First posted: September 10, 2013.
Topic(s):
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
7838
PROTOCOL: Opioid‐specific medication‐assisted therapy and its impact on criminal justice and overdose outcomes
Type: Journal Article
Authors: C. C. Strange, Sarah M. Manchak, Jordan M. Hyatt, Cory Haberman, Alisha Desai
Year: 2021
Publication Place: Oslo
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
7839
Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence
Type: Journal Article
Authors: Margo E. Godersky, Andrew J. Saxon, Joseph O. Merrill, Jeffrey H. Samet, Jane M. Simoni, Judith I. Tsui
Year: 2019
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
HIT & Telehealth See topic collection
,
Opioids & Substance Use See topic collection
7840
Provider and Patient-panel Characteristics Associated With Initial Adoption and Sustained Prescribing of Medication for Opioid Use Disorder
Type: Journal Article
Authors: G. Cochran, E. S. Cole, M. Sharbaugh, D. Nagy, A. J. Gordon, W. F. Gellad, J. Pringle, T. Bear, J. Warwick, C. Drake, C. H. Chang, E. DiDomenico, D. Kelley, J. Donohue
Year: 2021
Publication Place: United States
Topic(s):
Education & Workforce See topic collection
,
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection